Scinai Immunotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021	2020	2019	2018	2017	2016	2015
Market Capitalization	2	6	34	32	93	31	18	11	11
Market Cap Growth	-	-83.58%	5.57%	-65.86%	199.75%	72.20%	60.00%	1.41%	-
Enterprise Value	6	13	45	48	110	36	-2	4	1
PE Ratio	-0.29	-0.95	-4.10	-25.37	-3.03	-1.26	-1.86	-4.36	-3.88
PB Ratio	-1.17	-3.14	34.30	-7.74	-5.09	-3.54	1.14	1.57	1.18
P/FCF Ratio	-	-0.68	-4.45	-1.44	-3.92	-1.37	-4.41	-4.14	-3.84
P/OCF Ratio	-	-0.76	-4.54	-1.56	-4.30	-1.93	-6.38	-4.15	-3.85
EV/EBITDA Ratio	-	-2.46	-5.84	12.55	-5.08	-1.75	0.31	-1.79	-0.42
EV/EBIT Ratio	-1.15	-2.22	-5.50	15.28	-4.98	-1.74	0.31	-1.66	-0.40
EV/FCF Ratio	-	-1.59	-5.97	-2.18	-4.61	-1.60	0.50	-1.53	-0.39
Debt / Equity Ratio	-7.36	-12.24	29.52	-4.60	-2.02	-3.02	-	-	-
Debt / EBITDA Ratio	-	-4.12	-3.75	4.93	-1.71	-1.28	-	-	-
Debt / FCF Ratio	-	-2.66	-3.83	-0.86	-1.55	-1.17	-	-	-
Quick Ratio	4.22	6.08	7.17	0.17	3.86	3.53	10.94	19.01	21.74
Current Ratio	4.36	6.15	7.30	0.17	3.86	3.53	10.94	19.01	21.74
Interest Coverage	-	-	-	0.72	-2.54	-5.45	-2.17	-29.31	-423.96
Return on Equity (ROE)	267.60%	-345.70%	-291.80%	12.80%	231.60%	-832.80%	-78.80%	-31.80%	-33.80%
Return on Assets (ROA)	-49.30%	-23.40%	-30.80%	-5.80%	-106.50%	-109.80%	-55.70%	-26.80%	-27.60%
Return on Capital (ROIC)	-85.62%	-55.91%	-36.25%	13.95%	-118.30%	-122.05%	-42.05%	-46.46%	-33.70%
Earnings Yield	-544.03%	-104.83%	-24.36%	-3.94%	-32.98%	-79.43%	-53.87%	-22.91%	-25.80%
FCF Yield	-146.52%	-22.46%	-69.46%	-25.52%	-73.14%	-22.70%	-24.13%	-26.06%
Buyback Yield / Dilution	-140.18%	-33.57%	-27.37%	-35.70%	-24.95%	-30.04%	-48.80%	-28.03%	-94.38%
Total Shareholder Return	-140.18%	-33.57%	-27.37%	-35.70%	-24.95%	-30.04%	-48.80%	-28.03%	-94.38%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).